Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05873660 · ClinicalTrials.gov registry record
A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 5,360
- Enrollment target
NCT05873660 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 5,360 participants.
The verdict
NCT05873660 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 5,360 participants
- Enrollment target
Study Summary
The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,360 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2024-06-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05873660
The ClinicalTrials.gov registry entry for NCT05873660 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,360 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT05873660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05873660 about?
NCT05873660 is a clinical study titled "A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease". The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across ...
What is the current status of trial NCT05873660?
This trial is currently completed. The enrollment target is 5,360 participants. The study started on 2023-06-12. Estimated completion is 2024-06-24.
What interventions are being tested in trial NCT05873660?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT05873660?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.